Unmask-AF: Hiding abnormal signals to treat recurrent atrial fibrillation
Part of Heart & circulation clinical trials.
This study tests a new way to find and destroy hidden abnormal heart signals that may cause atrial fibrillation to come back after a prior ablation procedure. The goal is to see if this approach can stop AF from returning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have atrial fibrillation that keeps coming back (episodes lasting from 30 seconds up to more than a year).
- You have already had a first ablation procedure for AF (called pulmonary vein isolation or PVI).
- You are 40 years or older.
- You are willing to sign a consent form and follow all study visits.
- You are not pregnant, breastfeeding, or planning to become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares three approaches to treat persistent atrial fibrillation (AF) that lasts more than 7 days. It tests whether isolating the pulmonary veins alone is enough, or if also targeting low-voltage areas (scarred heart tissue) during either normal rhythm or AF works better.
This trial is testing a new way to treat atrial fibrillation by using a catheter to target the specific areas in the heart that trigger the irregular heartbeat. If you have persistent atrial fibrillation and haven't had prior catheter ablation, you may be eligible to join.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
This study tests a new approach to catheter ablation for people with persistent atrial fibrillation (a type of irregular heartbeat). It may be an option if you have not responded well to or could not tolerate a rhythm-control medication.
This trial tests a new method called pulsed field ablation (PFA) to treat irregular heartbeats (atrial fibrillation) by isolating the veins that carry blood to your heart. It aims to see how well this procedure works and if it's safe for you.
This study tests a new way to perform ablation (a type of heart procedure) for people with persistent atrial fibrillation (AF) that hasn't responded well to medication. The goal is to see if a targeted approach to the left atrium's back wall works better than standard ablation.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.